Do bisphosphonates inhibit direct fracture healing?

a laboratory investigation using an animal model

T. Savaridas*, R. J. Wallace, D. M. Salter, A. H. R. W. Simpson

*Corresponding author for this work

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Fracture repair occurs by two broad mechanisms: direct healing, and indirect healing with callus formation. The effects of bisphosphonates on fracture repair have been assessed only in models of indirect fracture healing.

A rodent model of rigid compression plate fixation of a standardised tibial osteotomy was used. Ten skeletally mature Sprague-Dawley rats received daily subcutaneous injections of 1 mu g/kg ibandronate (IBAN) and ten control rats received saline (control). Three weeks later a tibial osteotomy was rigidly fixed with compression plating. Six weeks later the animals were killed. Fracture repair was assessed with mechanical testing, radiographs and histology.

The mean stress at failure in a four-point bending test was significantly lower in the IBAN group compared with controls (8.69 Nmm(-2) (SD 7.63) vs 24.65 Nmm(-2) (SD 6.15); p = 0.017). On contact radiographs of the extricated tibiae the mean bone density assessment at the osteotomy site was lower in the IBAN group than in controls (3.7 mmAl (SD 0.75) vs 4.6 mmAl (SD 0.57); p = 0.01). In addition, histological analysis revealed progression to fracture union in the controls but impaired fracture healing in the IBAN group, with predominantly cartilage-like and undifferentiated mesenchymal tissue (p = 0.007).

Bisphosphonate treatment in a therapeutic dose, as used for risk reduction in fragility fractures, had an inhibitory effect on direct fracture healing. We propose that bisphosphonate therapy not be commenced until after the fracture has united if the fracture has been rigidly fixed and is undergoing direct osteonal healing.

Original languageEnglish
Pages (from-to)1263-1268
Number of pages6
JournalThe Journal of Bone and Joint Surgery - British volume
Volume95B
Issue number9
DOIs
Publication statusPublished - Sep 2013

Keywords

  • suppressed bone turnover
  • alendronate therapy
  • intervention trial
  • zoledronic acid
  • long bones
  • repair
  • rats
  • osteoperosis
  • microdamage
  • increases

Cite this

Do bisphosphonates inhibit direct fracture healing? a laboratory investigation using an animal model. / Savaridas, T.; Wallace, R. J.; Salter, D. M.; Simpson, A. H. R. W.

In: The Journal of Bone and Joint Surgery - British volume , Vol. 95B, No. 9, 09.2013, p. 1263-1268.

Research output: Contribution to journalArticle

@article{aaa48398417a4d74a3a76a79cfedc22a,
title = "Do bisphosphonates inhibit direct fracture healing?: a laboratory investigation using an animal model",
abstract = "Fracture repair occurs by two broad mechanisms: direct healing, and indirect healing with callus formation. The effects of bisphosphonates on fracture repair have been assessed only in models of indirect fracture healing.A rodent model of rigid compression plate fixation of a standardised tibial osteotomy was used. Ten skeletally mature Sprague-Dawley rats received daily subcutaneous injections of 1 mu g/kg ibandronate (IBAN) and ten control rats received saline (control). Three weeks later a tibial osteotomy was rigidly fixed with compression plating. Six weeks later the animals were killed. Fracture repair was assessed with mechanical testing, radiographs and histology.The mean stress at failure in a four-point bending test was significantly lower in the IBAN group compared with controls (8.69 Nmm(-2) (SD 7.63) vs 24.65 Nmm(-2) (SD 6.15); p = 0.017). On contact radiographs of the extricated tibiae the mean bone density assessment at the osteotomy site was lower in the IBAN group than in controls (3.7 mmAl (SD 0.75) vs 4.6 mmAl (SD 0.57); p = 0.01). In addition, histological analysis revealed progression to fracture union in the controls but impaired fracture healing in the IBAN group, with predominantly cartilage-like and undifferentiated mesenchymal tissue (p = 0.007).Bisphosphonate treatment in a therapeutic dose, as used for risk reduction in fragility fractures, had an inhibitory effect on direct fracture healing. We propose that bisphosphonate therapy not be commenced until after the fracture has united if the fracture has been rigidly fixed and is undergoing direct osteonal healing.",
keywords = "suppressed bone turnover, alendronate therapy, intervention trial, zoledronic acid, long bones, repair, rats, osteoperosis, microdamage, increases",
author = "T. Savaridas and Wallace, {R. J.} and Salter, {D. M.} and Simpson, {A. H. R. W.}",
year = "2013",
month = "9",
doi = "10.1302/0301-620X.95B9.31562",
language = "English",
volume = "95B",
pages = "1263--1268",
journal = "The Journal of Bone and Joint Surgery - British volume",
issn = "0301-620X",
publisher = "British Editorial Society of Bone and Joint Surgery",
number = "9",

}

TY - JOUR

T1 - Do bisphosphonates inhibit direct fracture healing?

T2 - a laboratory investigation using an animal model

AU - Savaridas, T.

AU - Wallace, R. J.

AU - Salter, D. M.

AU - Simpson, A. H. R. W.

PY - 2013/9

Y1 - 2013/9

N2 - Fracture repair occurs by two broad mechanisms: direct healing, and indirect healing with callus formation. The effects of bisphosphonates on fracture repair have been assessed only in models of indirect fracture healing.A rodent model of rigid compression plate fixation of a standardised tibial osteotomy was used. Ten skeletally mature Sprague-Dawley rats received daily subcutaneous injections of 1 mu g/kg ibandronate (IBAN) and ten control rats received saline (control). Three weeks later a tibial osteotomy was rigidly fixed with compression plating. Six weeks later the animals were killed. Fracture repair was assessed with mechanical testing, radiographs and histology.The mean stress at failure in a four-point bending test was significantly lower in the IBAN group compared with controls (8.69 Nmm(-2) (SD 7.63) vs 24.65 Nmm(-2) (SD 6.15); p = 0.017). On contact radiographs of the extricated tibiae the mean bone density assessment at the osteotomy site was lower in the IBAN group than in controls (3.7 mmAl (SD 0.75) vs 4.6 mmAl (SD 0.57); p = 0.01). In addition, histological analysis revealed progression to fracture union in the controls but impaired fracture healing in the IBAN group, with predominantly cartilage-like and undifferentiated mesenchymal tissue (p = 0.007).Bisphosphonate treatment in a therapeutic dose, as used for risk reduction in fragility fractures, had an inhibitory effect on direct fracture healing. We propose that bisphosphonate therapy not be commenced until after the fracture has united if the fracture has been rigidly fixed and is undergoing direct osteonal healing.

AB - Fracture repair occurs by two broad mechanisms: direct healing, and indirect healing with callus formation. The effects of bisphosphonates on fracture repair have been assessed only in models of indirect fracture healing.A rodent model of rigid compression plate fixation of a standardised tibial osteotomy was used. Ten skeletally mature Sprague-Dawley rats received daily subcutaneous injections of 1 mu g/kg ibandronate (IBAN) and ten control rats received saline (control). Three weeks later a tibial osteotomy was rigidly fixed with compression plating. Six weeks later the animals were killed. Fracture repair was assessed with mechanical testing, radiographs and histology.The mean stress at failure in a four-point bending test was significantly lower in the IBAN group compared with controls (8.69 Nmm(-2) (SD 7.63) vs 24.65 Nmm(-2) (SD 6.15); p = 0.017). On contact radiographs of the extricated tibiae the mean bone density assessment at the osteotomy site was lower in the IBAN group than in controls (3.7 mmAl (SD 0.75) vs 4.6 mmAl (SD 0.57); p = 0.01). In addition, histological analysis revealed progression to fracture union in the controls but impaired fracture healing in the IBAN group, with predominantly cartilage-like and undifferentiated mesenchymal tissue (p = 0.007).Bisphosphonate treatment in a therapeutic dose, as used for risk reduction in fragility fractures, had an inhibitory effect on direct fracture healing. We propose that bisphosphonate therapy not be commenced until after the fracture has united if the fracture has been rigidly fixed and is undergoing direct osteonal healing.

KW - suppressed bone turnover

KW - alendronate therapy

KW - intervention trial

KW - zoledronic acid

KW - long bones

KW - repair

KW - rats

KW - osteoperosis

KW - microdamage

KW - increases

U2 - 10.1302/0301-620X.95B9.31562

DO - 10.1302/0301-620X.95B9.31562

M3 - Article

VL - 95B

SP - 1263

EP - 1268

JO - The Journal of Bone and Joint Surgery - British volume

JF - The Journal of Bone and Joint Surgery - British volume

SN - 0301-620X

IS - 9

ER -